Sell. ARB’s supplied price and momentum data are predominantly bearish: the current price is $0.164085, with a reported 24-hour change of -10.20%, while the 7-day and 14-day changes are -17.14% and -23.19%. The 30-day change is also slightly negative at -1.93%, so the broader periods provided do not yet show a sustained recovery.

All five hourly moving averages are above the current price, ranging from $0.1823 for the 8-hour SMA to $0.1972 for the 144-hour SMA. The stated gaps, from about 10% to 17%, indicate substantial short-term weakness and reinforce the negative price momentum; the data do not show price reclaiming any of these averages.

The 1-hour RSI of 18 is deeply oversold and is the clearest counterargument to a strongly bearish reading, as it may be consistent with a short-term bounce. However, an oversold RSI alone does not establish that selling pressure has ended or confirm a reversal, and the 7-day RSI of 42 remains below the midpoint, offering no strong broader momentum signal in favor of buyers.

Trading activity is material, with 24-hour volume of 192,756,745 and volume equal to 17.30% of market capitalization. That establishes notable activity relative to market cap but does not identify whether buyers or sellers dominate, so it cannot outweigh the falling price, negative multiweek returns, and price below all listed moving averages.

There is a data inconsistency: the stated current price of $0.164085 is below the reported 24-hour low of $0.165767, so those figures cannot describe the same 24-hour range as presented. The all-time high of $2.39 also places the current price roughly 93% below that peak, but this long-term comparison alone does not indicate when or whether a recovery will occur.

The primary evidence supporting the Sell rating is the sharp 24-hour decline, continued losses over 7 and 14 days, and the current price sitting well below every supplied hourly moving average. The oversold hourly RSI warrants caution about near-term downside chasing and leaves room for a bounce, but without a confirming improvement in price or broader momentum, it is not enough to shift the overall assessment to Hold or Buy.